Active	Status	Sponsor type	Region	Phase	Filter
50 Active 39 Inactive 89 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

8 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Schmieder, Roland E
NCT06244758: Finerenone and Renal Oxidative Stress	Recruiting	3	75	Europe	Finerenone 20 MG Oral Tablet, Placebo	University of Erlangen-Nürnberg Medical School, Bayer	Type2diabetes	06/25	12/25
NCT05198674: SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN	Recruiting	N/A	1400	Europe, US, RoW	Renal Denervation (Symplicity Spyral™), Renal Angiography, Renal Denervation	Medtronic Vascular	Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus	11/26	11/29
Fietkau, Rainer
JADE, NCT06256588: A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma	Recruiting	3	864	Europe, Canada, Japan, US, RoW	Dostarlimab, Placebo	GlaxoSmithKline	Neoplasms, Head and Neck	05/28	07/29
TIGER PRO-Active, NCT04717739: - Daily Activity, Sleep and Neurocognitive Functioning Study	Recruiting	N/A	500	Europe	TTFields	NovoCure Ltd.	Glioblastoma	12/24	02/25
Achenbach, Stephan
PROTECT IV, NCT04763200: Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function	Recruiting	N/A	1252	Europe, Canada, US	Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®, IABP Intra-aortic balloon pump	Abiomed Inc.	Left Ventricular Dysfunction, Coronary Artery Disease	03/26	10/27
Hueber, Axel
ASSIST, NCT05171270: AsseSSing Impact in pSoriatic Treatment	Completed	N/A	503	Europe	Questionnaire	University of Oxford, Amgen	Psoriatic Arthritis	03/22	03/22
Wagner, Nicola
HARBOR, NCT04910685 / 2020-005173-28: () Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis	Recruiting	2/3	463	Europe, US, RoW	Elenestinib, BLU-263, Placebo	Blueprint Medicines Corporation	Indolent Systemic Mastocytosis, Monoclonal Mast Cell Activation Syndrome, Smoldering Systemic Mastocytosis	06/28	06/28
Kannenkeril, Dennis
NCT06244758: Finerenone and Renal Oxidative Stress	Recruiting	3	75	Europe	Finerenone 20 MG Oral Tablet, Placebo	University of Erlangen-Nürnberg Medical School, Bayer	Type2diabetes	06/25	12/25
Bihlmaier, Karl
No trials found
Kolwelter, Julie
No trials found
Gaede, Luise
No trials found
Bohr, Daniela
No trials found
Grieshaber-Bouyer, Ricardo
No trials found